Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › HORIZON

BRIDGE · Breakthrough Regulatory Innovation and Development throuGh sandbox Environments

HORIZONStatus: SIGNED1 November 202531 October 2028EU funding €5,199,814Call HORIZON-JU-IHI-2024-08-two-stage

BRIDGE aims to enhance healthcare innovation in Europe by developing a comprehensive framework for designing and operationalizing regulatory sandboxes. By addressing current regulatory limitations and engaging all stakeholders while ensuring compliance, the project seeks to create adaptable, fit-for-purpose methodologies that strengthen the regulatory ecosystem's capacity to promote healthcare innovation.The project’s objectives include identifying and analysing existing regulatory sandboxes across various domains and maturity levels, to determine how their modules can complement current healthcare regulations. BRIDGE will develop a horizon scanning methodology to continuously identify emerging technologies that challenge existing regulatory systems, analyzing their requirements for potential inclusion in regulatory sandboxes to ensure adaptability within an evolving innovation ecosystem.Through multi-stakeholder consultations, BRIDGE will elaborate and assess case studies, as well as develop operational checklists for module design and evidence packages to guide tailored sandbox launches. The project will also develop the Modular Operational Sandbox for Healthcare Innovation and Compliance (MOSAIC), an architectural model with interconnected modules featuring detailed functional specifications and mapped information flows aligned with specific case studies.Additionally, BRIDGE will engage key stakeholders—including regulatory bodies, industry consortia, HTA bodies, payers, healthcare providers, and patients—in an in-depth analysis, consultation, and consensus-building process to ensure the sandbox approach is comprehensive, functional, and adaptable to future advancements. Finally, the project will deliver comprehensive recommendations for the sandbox methodology’s end-to-end operations, encompassing legal, compliance, policy, and regulatory outputs to provide a robust implementation framework.

Consortium · 41 organisations

coordinator

VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK N.V.

BE · €1,097,773

participant

EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH

DE · €794,100

associatedPartner

Lilly Deutschland GmbH

DE

participant

EUROSCAN INTERNATIONAL NETWORK EV

DE · €473,940

associatedPartner

MSD R&D INNOVATION CENTRE LIMITED

UK

associatedPartner

SANOFI-AVENTIS DEUTSCHLAND GMBH

DE

associatedPartner

SANOFI WINTHROP INDUSTRIE

FR

participant

TAKEDA PHARMACEUTICALS INTERNATIONAL AG

CH

participant

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

IL

participant

TEKNOLOGIAN TUTKIMUSKESKUS VTT OY

FI · €519,007

participant

NOVARTIS PHARMA AG

CH

participant

FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES

BE

participant

ACADEMISCH ZIEKENHUIS GRONINGEN

NL · €229,894

participant

MERCK SHARP & DOHME CORP

US

associatedPartner

MERCKLE GMBH

DE

participant

F. HOFFMANN-LA ROCHE AG

CH

participant

CSL BEHRING GMBH

DE

associatedPartner

Merck, Sharp & Dohme de España, S.A.

ES

participant

MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

DE

participant

THE EUROPEAN ASSOCIATION MEDICAL DEVICES-NOTIFIED BODIES

BE · €110,625

participant

ASTELLAS PHARMA EUROPE BV

NL

associatedPartner

Pfizer Healthcare Ireland Unlimited Company

IE

participant

BIOGEN IDEC LIMITED

UK

participant

CHARITE - UNIVERSITAETSMEDIZIN BERLIN

DE · €228,123

participant

PFIZER INC

US

participant

BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE

DE · €402,613

associatedPartner

Merck Serono Ltd.

UK

associatedPartner

SANOFI R&D VACCINS

FR

participant

SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT

FR

participant

NOVO NORDISK A/S

DK

associatedPartner

ELI LILLY AND COMPANY LTD

UK

participant

FUNDACION PUBLICA ANDALUZA PROGRESO Y SALUD M.P.

ES · €270,313

participant

THE EUROPEAN MEDICINES AGENCY

NL · €197,595

participant

THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA

BE · €584,063

participant

JANSSEN PHARMACEUTICA NV

BE

participant

UNIVERSITE BOURGOGNE EUROPE

FR · €159,669

associatedPartner

Pfizer R&D UK Limited

UK

participant

TECHNISCHE UNIVERSITAET DRESDEN

DE · €132,103

associatedPartner

MSD Europe Belgium

BE

associatedPartner

MERCK HEALTHCARE KGAA

DE

participant

ELI LILLY AND COMPANY

US

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.